Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukoencephalopathy, Progressive Multifocal | 14 | 2019 | 113 | 2.250 |
Why?
|
| JC Virus | 16 | 2019 | 98 | 2.230 |
Why?
|
| Sequence Deletion | 4 | 2012 | 15 | 1.080 |
Why?
|
| HIV Infections | 6 | 2022 | 480 | 1.020 |
Why?
|
| Capsid Proteins | 7 | 2019 | 27 | 0.930 |
Why?
|
| Hepatitis C | 1 | 2022 | 45 | 0.780 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2014 | 88 | 0.740 |
Why?
|
| Simian virus 40 | 3 | 2013 | 10 | 0.660 |
Why?
|
| Neurons | 5 | 2019 | 335 | 0.560 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 116 | 0.510 |
Why?
|
| Polyomavirus Infections | 3 | 2014 | 26 | 0.510 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2013 | 15 | 0.500 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2014 | 13 | 0.460 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2013 | 4 | 0.440 |
Why?
|
| Tumor Virus Infections | 2 | 2013 | 16 | 0.410 |
Why?
|
| Genes, Viral | 3 | 2018 | 7 | 0.410 |
Why?
|
| Mitochondria | 2 | 2022 | 66 | 0.380 |
Why?
|
| Cerebellar Diseases | 1 | 2011 | 8 | 0.380 |
Why?
|
| Multiple Sclerosis | 4 | 2014 | 98 | 0.370 |
Why?
|
| Polyomavirus | 1 | 2011 | 6 | 0.370 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2013 | 17 | 0.340 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 146 | 0.320 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 185 | 0.310 |
Why?
|
| Humans | 23 | 2022 | 26260 | 0.270 |
Why?
|
| DNA Damage | 2 | 2022 | 26 | 0.250 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 8 | 0.240 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2021 | 15 | 0.240 |
Why?
|
| Brain | 4 | 2018 | 1603 | 0.220 |
Why?
|
| DNA, Viral | 4 | 2014 | 40 | 0.220 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 9 | 0.210 |
Why?
|
| Natalizumab | 4 | 2014 | 21 | 0.190 |
Why?
|
| HIV-1 | 2 | 2021 | 234 | 0.190 |
Why?
|
| Epoxide Hydrolases | 1 | 2021 | 11 | 0.190 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2021 | 4 | 0.190 |
Why?
|
| Adult | 10 | 2021 | 7516 | 0.190 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 17 | 0.190 |
Why?
|
| Ataxia Telangiectasia | 1 | 2020 | 1 | 0.180 |
Why?
|
| Telomere | 1 | 2020 | 7 | 0.180 |
Why?
|
| Antigens, Viral, Tumor | 3 | 2019 | 11 | 0.180 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2014 | 39 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2021 | 505 | 0.180 |
Why?
|
| Pyramidal Cells | 2 | 2012 | 33 | 0.180 |
Why?
|
| Genotype | 1 | 2021 | 350 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 111 | 0.170 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2013 | 16 | 0.170 |
Why?
|
| Animals | 5 | 2013 | 3551 | 0.170 |
Why?
|
| Base Sequence | 2 | 2012 | 100 | 0.160 |
Why?
|
| Capsid | 2 | 2014 | 12 | 0.160 |
Why?
|
| Virus Replication | 3 | 2020 | 51 | 0.160 |
Why?
|
| Macaca mulatta | 3 | 2013 | 60 | 0.160 |
Why?
|
| Meninges | 1 | 2019 | 7 | 0.160 |
Why?
|
| Choroid Plexus | 1 | 2019 | 6 | 0.160 |
Why?
|
| Female | 12 | 2021 | 14520 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 240 | 0.160 |
Why?
|
| Cell Line | 3 | 2020 | 262 | 0.160 |
Why?
|
| Oligodendroglia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Sequence Alignment | 2 | 2011 | 21 | 0.160 |
Why?
|
| Young Adult | 4 | 2021 | 1948 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 44 | 0.150 |
Why?
|
| Astrocytes | 1 | 2019 | 147 | 0.140 |
Why?
|
| Fibroblasts | 2 | 2008 | 58 | 0.130 |
Why?
|
| Male | 8 | 2021 | 14168 | 0.130 |
Why?
|
| Cerebellum | 2 | 2006 | 45 | 0.130 |
Why?
|
| Middle Aged | 6 | 2021 | 8541 | 0.120 |
Why?
|
| Meningitis, Aseptic | 1 | 2014 | 3 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2014 | 19 | 0.120 |
Why?
|
| HIV Seronegativity | 1 | 2014 | 17 | 0.110 |
Why?
|
| Herpesviridae | 1 | 2014 | 2 | 0.110 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 4 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2014 | 10 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 24 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2014 | 33 | 0.110 |
Why?
|
| DNA | 1 | 2014 | 104 | 0.110 |
Why?
|
| Virus Assembly | 1 | 2013 | 2 | 0.110 |
Why?
|
| Virion | 1 | 2013 | 14 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2013 | 14 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 47 | 0.110 |
Why?
|
| Meningoencephalitis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 12 | 0.110 |
Why?
|
| Coinfection | 1 | 2013 | 22 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2013 | 72 | 0.110 |
Why?
|
| Viral Core Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
| Genes, Regulator | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 4 | 0.100 |
Why?
|
| Viral Tropism | 1 | 2012 | 4 | 0.100 |
Why?
|
| Genome, Viral | 1 | 2012 | 11 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 59 | 0.100 |
Why?
|
| HIV | 2 | 2019 | 43 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 17 | 0.100 |
Why?
|
| Immunocompetence | 1 | 2011 | 4 | 0.090 |
Why?
|
| Apoptosis | 2 | 2021 | 190 | 0.080 |
Why?
|
| Mass Screening | 1 | 2011 | 174 | 0.080 |
Why?
|
| Gene Expression | 2 | 2021 | 196 | 0.080 |
Why?
|
| Zambia | 2 | 2021 | 17 | 0.080 |
Why?
|
| Transfection | 1 | 2008 | 111 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2021 | 54 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 154 | 0.070 |
Why?
|
| Biomarkers | 2 | 2021 | 556 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2006 | 96 | 0.060 |
Why?
|
| Viral Load | 2 | 2021 | 71 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 600 | 0.060 |
Why?
|
| Adolescent | 1 | 2011 | 2172 | 0.060 |
Why?
|
| Autopsy | 2 | 2019 | 328 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2021 | 60 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2005 | 60 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2005 | 80 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 349 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 8595 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2002 | 5 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 4 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2021 | 17 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 42 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 3 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2020 | 17 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 59 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 272 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 315 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2021 | 170 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 441 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cerebellar Cortex | 1 | 2019 | 7 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 262 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 343 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon beta-1a | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2014 | 8 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 56 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Protozoan | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cryptococcus | 1 | 2014 | 3 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Toxoplasmosis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Toxoplasma | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cryptococcosis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 7 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 94 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 15 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 107 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 41 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 82 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 3 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 6 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 82 | 0.030 |
Why?
|
| COS Cells | 1 | 2013 | 33 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 40 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 25 | 0.030 |
Why?
|
| Seizures | 1 | 2014 | 61 | 0.030 |
Why?
|
| Neuroglia | 1 | 2013 | 49 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 105 | 0.030 |
Why?
|
| Mutation | 1 | 2014 | 324 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 305 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 875 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1347 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1722 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2014 | 970 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2006 | 12 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2006 | 24 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 3283 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 43 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 594 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 710 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 9 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2002 | 9 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 114 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 158 | 0.010 |
Why?
|
| Survivors | 1 | 2002 | 63 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1069 | 0.010 |
Why?
|